|
Meet option 1 and 2 or option 1 and 3: | Aged 50 to 74
/Primary lung cancer patients with pathological diagnosis and without clinical treatment or patients with pulmonary lesions highly suspicious for lung cancer and without prior treatment
|
|
Without diseases as listed following: | Diabetes
/Other malignant tumors except lung cancer
/Asthma
/Severe liver dysfunction
/End-stage renal disease
/Acute inflammation
|
|
Inform Consent Form Signature | Yes
|
- General information
- Past History
- Exhaled Breath Collection Person
- Exhaled Breath Collection Date
- Data Entry Clerk
- Data Entry Date
- Quality Control Person
- Quality Control Date
|
Case Number/ID Number | 368424 |
|
Name | XUBA |
|
Gender | Male
|
|
Age | 59 岁 |
|
Height | 175 cm |
|
Weight | 62 kg |
|
Education | Middle School
|
|
Own Phone Number | 15230355161 |
|
Relatives Phone Number |
|
|
Relatives Name |
|
|
Smoking History | No
|
|
Drinking History | Yes
|
|
Surgical History | Other Surgery
|
|
Family Cancer History | No
|
|
Comorbidity | No
|
|
Pulmonary Nodules on Past Chest CT | Not Done
|
|
Exhaled Breath Collection Person | ZXZ |
|
Exhaled Breath Collection Date | 2020-01-02 yyyy-mm-dd |
|
Data Entry Clerk | ZXZ |
|
Data Entry Date | 2020-01-02 yyyy-mm-dd |
|
Quality Control Person |
|
|
Quality Control Date | yyyy-mm-dd |
- Tumor Marker
- FVC
- FVC%
- FEV1
- FEV1%
- FEV1/FVC
- MVV%
- DLCO SB%
- Tumor Shape on Chest CT
- Tumor Maximum Diameter on Chest CT
- Lymph Node on Chest CT
- PET-CT
|
Tumor Marker Increase | NSE
|
|
FVC | 3.66 L |
|
FVC% | 87.0 % |
|
FEV1 | 3.53 L |
|
FEV1% | 106.2 % |
|
FEV1/FVC | 96.52 % |
|
MVV% | 105.2 % |
|
DLCO SB% | 150.4 % |
|
Tumor Shape on Chest CT | Ground Glass Nodule
|
|
Tumor Maximum Diameter on Chest CT | 2.8 cm |
|
Lymph Node on Chest CT | cN1-2(-)
|
|
PET-CT SUVmax | Not Done
|
|
Tumor Location | Right Upper Lobe
|
|
Surgical Approach | Single Port VATS
|
|
Type of Resection | Lobectomy
|
|
Operative Time | 105 minutes |
|
Intraoperative Blood Loss | 30 ml |
|
Intraoperative Blood Transfusion |
|
Surgeon Name | Tianpeng Xie
|
|
Surgical Margin | No Residual Tumor
|
|
Pathological Type | Acinar Predominant Adenocarcinoma
|
|
Lymphovascular Invasion | No
|
|
Perineural Invasion | No
|
|
Gene Mutation | EGFR-21(+)
|
|
pT Stage, Eighth Edition | T1c
|
|
pN Stage, Eighth Edition | N0
|
|
Stations of N1 Lymph Nodes | Three Stations
|
|
Numbers of N1 Lymph Nodes | 13 个 |
|
Numbers of Metastatic N1 Lymph Nodes | 0 个 |
|
Stations of N2 Lymph Nodes | Four Stations
|
|
Numbers of N2 Lymph Nodes | 23 个 |
|
Numbers of Metastatic N2 Lymph Nodes | 0 个 |
|
Dissection of Station 7 | Yes
|
|
Highest N2 Status | Negative
|
|
Types of Lymph Node Dissection | Systematic Lymph Node Dissection
|
|
pM Stage, Eighth Edition | M0
|
|
pTNM Stage, Eighth Edition | Stage IA3
|
|
Postoperative Complications | No
|
|
Non-Surgical Treatment |
|
Admission Date | 2019-12-30 yyyy-mm-dd |
|
Discharge Date | 2020-01-07 yyyy-mm-dd |
|
Surgery Date | 2020-01-02 yyyy-mm-dd |